Back
ARS Pharmaceuticals Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
35
SPRY
ARS Pharmaceuticals
Last Price:
14.87
Seasonality Move:
-2.91%
Sell
42
LBPH
Longboard Pharmaceuticals
Last Price:
33.39
Seasonality Move:
-17.05%
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
Is ARS Pharmaceuticals a Buy, Sell or Hold?
- The current ARS Pharmaceuticals [SPRY] share price is $14.05. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- SPRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Longboard Pharmaceuticals (LBPH)
is a Sell
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $29.31. The Score for LBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRY Stock Price Chart
What is ARS Pharmaceuticals's stock price today?
-
The ARS Pharmaceuticals share price today is $14.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $29.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 63.23 | Buy |
Chaikin Money Flow: | 629993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.06 | Sell |
Relative Strength Index (14 RSI): | 38.7 | Sell |
Chaikin Money Flow: | 434120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SPRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.65 | Buy |
20-day SMA: | 12.71 | Buy |
50-day SMA: | 11.83 | Buy |
200-day SMA: | 8.83 | Buy |
8-day EMA: | 12.95 | Buy |
20-day EMA: | 12.6 | Buy |
50-day EMA: | 11.79 | Buy |
200-day EMA: | 9.39 | Buy |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.33 | Sell |
20-day SMA: | 34.08 | Sell |
50-day SMA: | 34.97 | Sell |
200-day SMA: | 23.09 | Buy |
8-day EMA: | 31.57 | Sell |
20-day EMA: | 33.23 | Sell |
50-day EMA: | 32.69 | Sell |
200-day EMA: | 24.04 | Buy |
ARS Pharmaceuticals Earnings Growth & SPRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.26 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
ARS Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |